Abl Kinase Domain Mutations in Imatinib-treated Egyptian Patients with Chronic Myeloid Leukemia

Yasser H Elnahass^1*, Hossam K Mahmoud², Fahmy T Ali³, Mohamed R Mohamed³, Mahmoud M Said³, Mohamad Abdel Moaty Samra², Mohamed AM Ali³, Amir Salem⁴ and Wafaa H ElMetnawy⁵

¹Department of Clinical Pathology, BMT Lab Unit, National Cancer Institute, Cairo University, Egypt

²Department of Hematology and BMT, National Cancer Institute, Cairo University, Egypt

³Department of Biochemistry, Faculty of Science, Ain Shams University, Egypt

⁴Department of Pathology, National Research Center, Cairo, Egypt

⁵Clinical Oncology Center, School of Medicine, Cairo University, Egypt

^*Corresponding Author: Yasser H Elnahass, Department of Clinical Pathology, BMT Lab Unit, National Cancer Institute, Cairo University, Egypt, Tel: +201112013535 Email: